Skip to main content
NIH funding notice PAR-16-290

HIV/AIDS Vaccine Facility (C06)

Closed on August 1, 2016.

Posted
May 25, 2016
Close date
August 1, 2016
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $4,900,000 in first-year total cost, median $4,900,000.

Most frequent study sections

  1. Scientific and Technical Review Board on Biomedical and Behavioral Research Facilities[STOD]1

Most frequent institutions

  1. DUKE UNIVERSITY1
Competing awards under PAR-16-290 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2017Duke Clinical Good Manufacturing Practices Facility for HIV/AIDS Vaccine Production1C06OD023830-01HAYNES, BARTON F.DUKE UNIVERSITY, NC$4,900,000STOD

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.